Display options
Share it on

Scand J Immunol. 2021 Dec 28;e13135. doi: 10.1111/sji.13135. Epub 2021 Dec 28.

Chagas disease, COVID-19 and P2X7 receptor.

Scandinavian journal of immunology

Caroline de Souza Ferreira Pereira, Robson Xavier Faria

Affiliations

  1. Laboratory of Evaluation and Promotion of Environmental Health, Oswaldo Cruz Institute (IOC), Rio de Janeiro, Brazil.

PMID: 34963022 DOI: 10.1111/sji.13135

[No abstract available.]

References

  1. Álvarez-Hernández DA, Franyuti-Kelly GA, Díaz-López-Silva RM, González-Chávez A, González-Hermosillo-Cornejo D, Vázquez-López R. Chagas disease: current perspectives on a forgotten disease. Rev Méd Hosp Gen (Méx). 2018;81:154-164. - PubMed
  2. Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391:82-94. - PubMed
  3. Zaidel EJ, Forsyth CJ, Novick G, et al. COVID-19: implications for people with chagas disease. Global Heart. 2020;15:69. - PubMed
  4. Akhmerov A, Marbán E. COVID-19 and the heart. Circ Res. 2020;126:1443-1455. - PubMed
  5. Adinolfi E, Giuliani LA, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F. The P2X7 receptor: a main player in inflammation. Biochem Pharmacol. 2018;151:234-244. - PubMed
  6. Souza VCG, dos Santos JT, Cabral FL, et al. Evaluation of P2X7 receptor expression in peripheral lymphocytes and immune profile from patients with indeterminate form of Chagas disease. Microb Pathog. 2017;104:32-38. - PubMed
  7. Pacheco PAF, Faria RXF. The potential involvement of P2X7 receptor in COVID-19 pathogenesis: a new therapeutic target? Scand J Immunol. 2021;93(2):1-9. - PubMed

Publication Types

Grant support